JOINN adheres to the purpose of "Serve for Drug Innovation,
Focus on Safety Assessments and Monitoring of Drugs Throughout Life Cycles"

(1) PROPOSED PARTIAL REPURCHASE AND CANCELLATION OF THE RESTRICTED A SHARES; AND (2) PROPOSED PARTIAL CANCELLATION OF THE STOCK OPTIONS

(1) PROPOSED PARTIAL REPURCHASE AND CANCELLATION OF THE RESTRICTED A SHARES; AND (2) PROPOSED PARTIAL CANCELLATION OF THE STOCK OPTIONS

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2021 (REVISED)

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2021 (REVISED)

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2021

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2021

LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

ANNOUNCEMENT ON ESTIMATED GROWTH IN RESULTS FOR THE HALF YEAR OF 2021

ANNOUNCEMENT ON ESTIMATED GROWTH IN RESULTS FOR THE HALF YEAR OF 2021

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2021

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2021

2020 Environmental, Social and Governance Report

2020 Environmental, Social and Governance Report

Leave us a message

Thank you for your attention to JOINN. Please fill in the information below, and we will contact you promptly.

Message

Message

top